Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Shoji F, Takeoka H, Kozuma Y, Toyokawa G, Yamazaki K, Ichiki M, Takeo S.

Lung Cancer. 2019 Aug 14;136:45-51. doi: 10.1016/j.lungcan.2019.08.006. [Epub ahead of print]

PMID:
31437663
2.

Endoscopic Treatment of Sinonasal Glomangiopericytoma: A Case Report in Light of the Literature.

Saito Y, Ohta N, Konosu-Fukaya S, Shoji F, Suzuki T, Noguchi N, Kakuta R, Ikeda R, Yamazaki M, Kusano Y, Ishida Y, Satake M, Ise K, Kagaya Y, Tamura R, Murakami K, Nakamura Y.

Yonago Acta Med. 2019 Jun 20;62(2):236-239. doi: 10.33160/yam.2019.06.009. eCollection 2019 Jun.

3.

First Case of a Primary Lung Granulosa Cell Tumor With a Mutation in the Forkhead Box L2 Gene.

Izuwa A, Toyokawa G, Shoji F, Yamazaki K, Momosaki S, Furuya K, Yamada Y, Oda Y, Takeo S.

J Thorac Oncol. 2019 May;14(5):e100-e102. doi: 10.1016/j.jtho.2018.12.029. No abstract available.

PMID:
31027742
4.

Significance of the Red Blood Cell Distribution Width in Resected Pathologic Stage I Nonsmall Cell Lung Cancer.

Toyokawa G, Shoji F, Yamazaki K, Shimokawa M, Takeo S.

Semin Thorac Cardiovasc Surg. 2019 Apr 19. pii: S1043-0679(19)30134-0. doi: 10.1053/j.semtcvs.2019.04.011. [Epub ahead of print]

PMID:
31009697
5.

Clinical impact of preoperative immunonutritional status in patients undergoing surgical resection of lung cancer.

Shoji F.

J Thorac Dis. 2019 Mar;11(Suppl 3):S408-S412. doi: 10.21037/jtd.2018.11.118. No abstract available.

6.

The expression of 11 beta hydroxysteroid dehydrogenase in severe allergic rhinitis.

Ohta N, Noguchi N, Takahashi T, Suzuki T, Kakuta R, Suzuki Y, Awataguchi T, Suzuki T, Takahashi Y, Shoji F, Wada K, Kawano T, Ono I, Kusano Y, Miyasaka T, Osafune H, Matsutani S, Yaginuma Y, Ishida Y, Saito Y, Yamazaki M, Ikeda R.

Otolaryngol Pol. 2018 Oct 5;73(2):18-22. doi: 10.5604/01.3001.0012.6143.

7.

Novel Antifungal Compound Z-705 Specifically Inhibits Protein Kinase C of Filamentous Fungi.

Sugahara A, Yoshimi A, Shoji F, Fujioka T, Kawai K, Umeyama H, Komatsu K, Enomoto M, Kuwahara S, Hagiwara D, Katayama T, Horiuchi H, Miyazawa K, Nakayama M, Abe K.

Appl Environ Microbiol. 2019 May 2;85(10). pii: e02923-18. doi: 10.1128/AEM.02923-18. Print 2019 May 15.

PMID:
30902853
8.

HMGB1 blockade significantly improves luminal fibrous obliteration in a murine model of bronchiolitis obliterans syndrome.

Takamori S, Shoji F, Okamoto T, Kozuma Y, Matsubara T, Haratake N, Akamine T, Katsura M, Takada K, Toyokawa G, Tagawa T, Maehara Y.

Transpl Immunol. 2019 Apr;53:13-20. doi: 10.1016/j.trim.2018.11.007. Epub 2018 Dec 1.

PMID:
30508580
9.

Perioperative serum and urine metabolome analyses in patients with hepatocellular carcinoma undergoing partial hepatectomy.

Kajiura D, Yamanaka-Okumura H, Hirayama A, Tatano H, Endo K, Honma M, Igarashi K, Shoji F, Ikeda S, Yamaguchi N, Katayama T, Morine Y, Imura S, Utsunomiya T, Soga T, Tomita M, Shimada M.

Nutrition. 2019 Feb;58:110-119. doi: 10.1016/j.nut.2018.06.002. Epub 2018 Aug 7.

PMID:
30391689
10.

A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer.

Okamoto T, Yano T, Shimokawa M, Takeo S, Yamazaki K, Sugio K, Takenoyama M, Nagashima A, Tsukamoto S, Hamatake M, Yokoyama H, Ueda H, Motohiro A, Tagawa T, Shoji F, Kometani T, Saito G, Fukuyama Y, Toyokawa G, Osoegawa A, Emi Y, Maehara Y; Kyushu University Lung Surgery Study Group (KLSS) Japan.

Lung Cancer. 2018 Oct;124:255-259. doi: 10.1016/j.lungcan.2018.08.015. Epub 2018 Aug 19.

PMID:
30268470
11.

Seasonal and meteorological impacts on primary spontaneous pneumothorax.

Ogata H, Matsumoto K, Nakatomi K, Nakashima N, Shoji F, Koto H.

J Thorac Dis. 2018 Jul;10(7):3957-3964. doi: 10.21037/jtd.2018.06.17.

12.

Impact of Preoperative Ultrasonography Screening for Carotid Artery Stenosis in Lung Cancer Patients.

Shoji F, Takeo S, Yamazaki K, Miura N, Katsura M, Oku Y, Shimokawa M.

Ann Thorac Surg. 2018 Oct;106(4):1047-1054. doi: 10.1016/j.athoracsur.2018.04.072. Epub 2018 May 28.

PMID:
29852144
13.

Postoperative Management of Multiple Primary Cancers Associated with Non-small Cell Lung Cancer.

Shoji F, Yamazaki K, Miura N, Katsura M, Oku Y, Takeo S, Maehara Y.

Anticancer Res. 2018 Jun;38(6):3773-3778. doi: 10.21873/anticanres.12660.

PMID:
29848742
14.

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score-matched analysis.

Takamori S, Tagawa T, Toyokawa G, Ueo H, Shimokawa M, Kinoshita F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Katsura M, Takada K, Hirai F, Shoji F, Okamoto T, Oda Y, Maehara Y.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1539. [Epub ahead of print]

15.

Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung.

Okamoto T, Takada K, Sato S, Toyokawa G, Tagawa T, Shoji F, Nakanishi R, Oki E, Koike T, Nagahashi M, Ichikawa H, Shimada Y, Watanabe S, Kikuchi T, Akazawa K, Lyle S, Takabe K, Okuda S, Sugio K, Wakai T, Tsuchida M, Maehara Y.

Ann Surg Oncol. 2018 Jun;25(6):1564-1571. doi: 10.1245/s10434-018-6401-1. Epub 2018 Mar 2.

PMID:
29500766
16.

PD-L1 expression according to the EGFR status in primary lung adenocarcinoma.

Takada K, Toyokawa G, Tagawa T, Kohashi K, Shimokawa M, Akamine T, Takamori S, Hirai F, Shoji F, Okamoto T, Oda Y, Maehara Y.

Lung Cancer. 2018 Feb;116:1-6. doi: 10.1016/j.lungcan.2017.12.003. Epub 2017 Dec 7.

PMID:
29413045
17.

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.

Nagata Y, Hirayama A, Ikeda S, Shirahata A, Shoji F, Maruyama M, Kayano M, Bundo M, Hattori K, Yoshida S, Goto YI, Urakami K, Soga T, Ozaki K, Niida S.

Biomark Res. 2018 Jan 22;6:5. doi: 10.1186/s40364-018-0119-x. eCollection 2018.

18.

Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.

Takamori S, Toyokawa G, Okamoto T, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takada K, Katsura M, Hirai F, Shoji F, Tagawa T, Oda Y, Honda H, Maehara Y.

Ann Surg Oncol. 2018 May;25(5):1229-1236. doi: 10.1245/s10434-017-6328-y. Epub 2018 Jan 11.

PMID:
29327178
19.

Dynamic Metabolomics Reveals that Insulin Primes the Adipocyte for Glucose Metabolism.

Krycer JR, Yugi K, Hirayama A, Fazakerley DJ, Quek LE, Scalzo R, Ohno S, Hodson MP, Ikeda S, Shoji F, Suzuki K, Domanova W, Parker BL, Nelson ME, Humphrey SJ, Turner N, Hoehn KL, Cooney GJ, Soga T, Kuroda S, James DE.

Cell Rep. 2017 Dec 19;21(12):3536-3547. doi: 10.1016/j.celrep.2017.11.085.

20.

Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer.

Haratake N, Toyokawa G, Takada K, Kozuma Y, Matsubara T, Takamori S, Akamine T, Katsura M, Shoji F, Okamoto T, Oda Y, Maehara Y.

Ann Thorac Surg. 2018 Feb;105(2):448-454. doi: 10.1016/j.athoracsur.2017.09.025. Epub 2017 Dec 15.

PMID:
29254651
21.

Successful resection of a tracheal metastasis of rectal cancer: a case report.

Akamine T, Toyokawa G, Kohashi K, Matsubara T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Shoji F, Okamoto T, Oda Y, Maehara Y.

J Thorac Dis. 2017 Sep;9(9):E797-E800. doi: 10.21037/jtd.2017.07.94. Erratum in: J Thorac Dis. 2017 Oct;9(10 ):E978.

22.

Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma.

Toyokawa G, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Takada K, Katsura M, Shimokawa M, Shoji F, Okamoto T, Maehara Y.

J Thorac Dis. 2017 Sep;9(9):2942-2951. doi: 10.21037/jtd.2017.07.108.

23.

Association Between PD-L1 Expression and Metabolic Activity on 18F-FDG PET/CT in Patients with Small-sized Lung Cancer.

Takada K, Toyokawa G, Tagawa T, Kohashi K, Akamine T, Takamori S, Hirai F, Shoji F, Okamoto T, Oda Y, Maehara Y.

Anticancer Res. 2017 Dec;37(12):7073-7082.

PMID:
29187498
24.

Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.

Shoji F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Takamori S, Katsura M, Toyokawa G, Okamoto T, Maehara Y.

Anticancer Res. 2017 Dec;37(12):6997-7003.

PMID:
29187486
25.

A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis.

Matsubara T, Toyokawa G, Yamada Y, Nabeshima K, Haratake N, Kozuma Y, Akamine T, Takamori S, Shoji F, Okamoto T, Maehara Y.

Anticancer Res. 2017 Dec;37(12):6937-6941.

PMID:
29187476
26.

The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.

Takada K, Toyokawa G, Shoji F, Okamoto T, Maehara Y.

Clin Lung Cancer. 2018 Mar;19(2):120-129. doi: 10.1016/j.cllc.2017.10.014. Epub 2017 Oct 28. Review.

PMID:
29153898
27.

Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.

Shoji F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Takamori S, Katsura M, Toyokawa G, Okamoto T, Maehara Y.

Surg Oncol. 2017 Dec;26(4):483-488. doi: 10.1016/j.suronc.2017.09.006. Epub 2017 Sep 25.

PMID:
29113668
28.

Assessment of pleural air leakage using digital chest drainage system after surgical pulmonary resection: Comparison of visible alveolar air leakage with the digital value measured by a digital chest drainage system.

Mori R, Yamazaki K, Shoji F, Kouso H, Ushijima C, Miura N, Takenaka T, Takeo S.

PLoS One. 2017 Nov 6;12(11):e0187705. doi: 10.1371/journal.pone.0187705. eCollection 2017.

29.

Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study.

Shoji F, Miura N, Matsubara T, Akamine T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Toyokawa G, Takenaka T, Yamazaki K, Okamoto T, Takeo S, Maehara Y.

Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):389-394. doi: 10.1093/icvts/ivx337.

PMID:
29049803
30.

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.

Katsura M, Shoji F, Okamoto T, Shimamatsu S, Hirai F, Toyokawa G, Morodomi Y, Tagawa T, Oda Y, Maehara Y.

Cancer Sci. 2018 Jan;109(1):154-165. doi: 10.1111/cas.13422. Epub 2017 Nov 9.

31.

Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients.

Shoji F, Yamashita N, Inoue Y, Kozuma Y, Toyokawa G, Hirai F, Ito K, Tagawa T, Okamoto T, Maehara Y.

Anticancer Res. 2017 Oct;37(10):5871-5876.

PMID:
28982914
32.

Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography.

Takada K, Toyokawa G, Okamoto T, Baba S, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takamori S, Katsura M, Shoji F, Honda H, Oda Y, Maehara Y.

Cancer Med. 2017 Nov;6(11):2552-2561. doi: 10.1002/cam4.1215. Epub 2017 Oct 4.

33.

Invasive features of small-sized lung adenocarcinoma adjoining emphysematous bullae.

Toyokawa G, Shimokawa M, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Takada K, Katsura M, Shoji F, Okamoto T, Maehara Y.

Eur J Cardiothorac Surg. 2018 Feb 1;53(2):372-378. doi: 10.1093/ejcts/ezx295.

PMID:
28958080
34.

Association of perfectionistic and dependent dysfunctional attitudes with subthreshold depression.

Horiuchi S, Aoki S, Takagaki K, Shoji F.

Psychol Res Behav Manag. 2017 Aug 14;10:271-275. doi: 10.2147/PRBM.S135912. eCollection 2017.

35.

[A Case of Merkel Cell Carcinoma Complicated with Severe Thrombocytopenia Treated with Carboplatin/Etoposide Regimen after Surgery].

Saito Y, Kiba T, Takahashi T, Hirakawa H, Saito M, Otomo C, Sato M, Watanabe Y, Sakaguchi M, Kadota R, Noguchi N, Suzuki T, Awataguchi T, Shoji F, Ota N.

Gan To Kagaku Ryoho. 2017 Aug;44(8):685-687. Japanese.

PMID:
28860441
36.

Discrepancy in Programmed Cell Death-Ligand 1 Between Primary and Metastatic Non-small Cell Lung Cancer.

Takamori S, Toyokawa G, Okamoto I, Takada K, Kozuma Y, Matsubara T, Haratake N, Akamine T, Katsura M, Mukae N, Shoji F, Okamoto T, Oda Y, Iwaki T, Iihara K, Nakanishi Y, Maehara Y.

Anticancer Res. 2017 Aug;37(8):4223-4228.

PMID:
28739710
37.

Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non-Small-cell Lung Cancer: A Mini-review.

Takamori S, Toyokawa G, Takada K, Shoji F, Okamoto T, Maehara Y.

Clin Lung Cancer. 2018 Jan;19(1):12-16. doi: 10.1016/j.cllc.2017.06.015. Epub 2017 Jul 6. Review.

PMID:
28739315
38.

Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression.

Takada K, Okamoto T, Tominaga M, Teraishi K, Akamine T, Takamori S, Katsura M, Toyokawa G, Shoji F, Okamoto M, Oda Y, Hoshino T, Maehara Y.

PLoS One. 2017 Jul 20;12(7):e0181598. doi: 10.1371/journal.pone.0181598. eCollection 2017.

39.

Surgical Repair of Pleuroperitoneal Communication with Continuous Ambulatory Peritoneal Dialysis.

Shoji F, Katsura M, Haratake N, Akamine T, Takamori S, Takada K, Toyokawa G, Okamoto T, Maehara Y.

Thorac Cardiovasc Surg. 2019 Mar;67(2):147-150. doi: 10.1055/s-0037-1603621. Epub 2017 Jun 5.

PMID:
28582790
40.

Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.

Fujishita T, Okamoto T, Akamine T, Takamori S, Takada K, Katsura M, Toyokawa G, Shoji F, Shimokawa M, Oda Y, Nakabeppu Y, Maehara Y.

Lung Cancer. 2017 Jul;109:52-57. doi: 10.1016/j.lungcan.2017.04.012. Epub 2017 Apr 24.

PMID:
28577950
41.

Endoscopic surgical management of sinonasal inverted papilloma extending to frontal sinuses.

Takahashi Y, Shoji F, Katori Y, Hidaka H, Noguchi N, Abe Y, Kakuta RK, Suzuki T, Suzuki Y, Ohta N, Kakehata S, Okamoto Y.

Otolaryngol Pol. 2016 Nov 10;70(6):26-32. doi: 10.5604/01.3001.0009.3801.

42.

Significance of the Preoperative CONUT Score in Predicting Postoperative Disease-free and Overall Survival in Patients with Lung Adenocarcinoma with Obstructive Lung Disease.

Akamine T, Toyokawa G, Matsubara T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Shoji F, Okamoto T, Maehara Y.

Anticancer Res. 2017 May;37(5):2735-2742.

PMID:
28476853
43.

Surgical Treatment and Outcome of Patients with De Novo Lung Cancer After Liver Transplantation.

Shoji F, Toyokawa G, Harada N, Itoh S, Harimoto N, Ikegami T, Okamoto T, Soejima Y, Yoshizumi T, Maehara Y.

Anticancer Res. 2017 May;37(5):2619-2623.

PMID:
28476836
44.

Mucinous adenocarcinoma of the thymus: report of a case.

Kinoshita F, Shoji F, Takada K, Toyokawa G, Okamoto T, Yano T, Oda Y, Maehara Y.

Gen Thorac Cardiovasc Surg. 2018 Feb;66(2):111-115. doi: 10.1007/s11748-017-0781-1. Epub 2017 May 4.

PMID:
28474330
45.

Pulmonary vein stump thrombosis after left pneumonectomy, diagnosed based on a high plasma D-dimer level: a case report.

Kamori T, Toyokawa G, Okamoto T, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Takada K, Katsura M, Shoji F, Maehara Y.

J Thorac Dis. 2017 Mar;9(3):E210-E214. doi: 10.21037/jtd.2017.02.58.

46.

Computed Tomography Features of Lung Adenocarcinomas With Programmed Death Ligand 1 Expression.

Toyokawa G, Takada K, Okamoto T, Shimokawa M, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Katsura M, Shoji F, Oda Y, Maehara Y.

Clin Lung Cancer. 2017 Nov;18(6):e375-e383. doi: 10.1016/j.cllc.2017.03.008. Epub 2017 Mar 16.

PMID:
28385373
47.

Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.

Okamoto T, Kohno M, Ito K, Takada K, Katsura M, Morodomi Y, Toyokawa G, Shoji F, Maehara Y.

Anticancer Res. 2017 Apr;37(4):1729-1735.

PMID:
28373435
48.

Relevance Between Programmed Death Ligand 1 and Radiologic Invasiveness in Pathologic Stage I Lung Adenocarcinoma.

Toyokawa G, Takada K, Okamoto T, Kawanami S, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Katsura M, Yamada Y, Shoji F, Baba S, Kamitani T, Oda Y, Honda H, Maehara Y.

Ann Thorac Surg. 2017 Jun;103(6):1750-1757. doi: 10.1016/j.athoracsur.2016.12.025. Epub 2017 Mar 24.

PMID:
28347537
49.

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.

Takada K, Toyokawa G, Okamoto T, Shimokawa M, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takamori S, Katsura M, Shoji F, Oda Y, Maehara Y.

Clin Lung Cancer. 2017 Sep;18(5):572-582.e1. doi: 10.1016/j.cllc.2017.02.004. Epub 2017 Mar 2.

PMID:
28318951
50.

Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer.

Toyokawa G, Takada K, Okamoto T, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takamori S, Katsura M, Shoji F, Hamamoto R, Oda Y, Maehara Y.

Anticancer Res. 2017 Mar;37(3):1393-1401.

PMID:
28314309

Supplemental Content

Support Center